You are here

Innovative Healthcare Committee

Mission

The IHC aims to be a reliable policy partner to the Belgian government and local US embassy to Belgium to ensure that new healthcare-related legislation and policies add value to, and benefit, the entire healthcare ecosystem.

The IHC is a unique cross-functional body covering nearly the whole health industry in Belgium. It contributes to ongoing legislative and policy discussions by:

  • Promoting the regular exchange of viewpoints between large companies and federal and regional officials on important healthcare challenges (ageing, economic crisis, patients expectations ...)
  • Ensuring efficient coordination of regionalized matters in the three Regions, prioritizing healthcare interests as State Reform is implemented

It also will be able to support the Healthcare Committee of AmCham EU to ensure that health is seen as an important driver for wealth and economic growth; it therefore supports the EU health agenda towards affordable, sustainable and innovative health systems.

GOALS & OBJECTIVES

  • Give Government/Public Affairs Managers and subject matter specialists of AmCham Belgium members a forum to exchange views with Belgian officials and US embassy officials.
  • Engage in constructive, high-level discussions with Belgian policymakers and US officials from the federal and regional governments on relevant topics
  • Promote a vigorous debate on the merits of building healthcare priorities/issues and investing in Belgium among the broader AmCham Belgium membership
  • Be a partner to the AmCham EU Healthcare committee and promote the sharing of local learnings/best practices amongst European countries, possibly leveraging an annual AmCham EU meeting with local AmChams (and engage/educate US embassies’ officers across Europe on key healthcare policy issues).
     

Committee members

Mr. Kris Schellens

Managing Director BeLux, Biogen Belgium NV
Chair

Mr. Joan Van Loon

Belux Enterprise Unit Leader Public, Life Sciences, Telco & Utilities, IBM Belgium BVBA/SPRL
Vice Chair

Ms. Kathleen Swaelen

Government Affairs Manager, 3M Belgium (Diegem)
Vice Chair

Mr. Philip Alliet

CEO Belux, Aon Belgium BVBA (Diegem)
Member

Ms. Elfriede Berger

Health Economics & Reimbursement Lead, Johnson & Johnson Medical NV
Member

Mr. Timmy Boerjan

Market Access Head, Baxter Belgium SPRL
Member

Mr. Peter Bogaert

Managing Partner, Covington & Burling LLP
Member

Mr. Kristof Callebaut

Managing Director Belux & Commercial Finance Manager Benelux, GE Healthcare
Member

Mr. Frédéric Clais

Country Manager, Eli Lilly Benelux NV/SA
Member

Mr. Jan Denecker

Marketing Manager Healthcare, UPS Belgium NV
Member

Ms. Danny Dumon

Commercial Advisor, US Embassy
Member

Mr. Dirk Hemelsoet

Policy & Government Relations Manager, MSD Belgium BVBA/SPRL
Member

Ms. Marieke Huysentruyt

Co-Founder and Chief Behavioural Economist, i-propeller NV/SA
Member

Mr. Antoine Mialhe

Senior Director, Strategic Communications, FTI Consulting
Member

Ms. Olivia Natens

Country Director Belux, Medtronic Belgium NV/SA
Member

Ms. Michèle Paque

Head of Business Development North West Europe, Quintiles Belgium NV
Member

Mr. Julien Patris

Senior Manager, Corporate Affairs BeLux, Celgene
Member

Mr. Bart Schelfhout

Head of Government Affairs, Bristol-Myers Squibb Belgium SA
Member

Mr. Bart Torbeyns

Associate Director Public Policy and Government Relations, Sanofi Belgium NV
Member

Mr. Karel Van De Sompel

Country Manager & Managing Director Pfizer Belgium / Global Innovative Pharma Business Head BeLux, Pfizer NV/SA
Member

Ms. Tineke Van Hooland

External Affairs Director, AbbVie SA
Member

Mr. Vincent Vanwijnsberghe

External Affairs Manager, Alcon NV
Member

Ms. Corianne Oosterbaan

Public Affairs Assistant, AmCham Belgium
Staff Liaison